Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Rönesans secures prodigious ranking in ENR list: 9th European largest international contracting company, and 38th worldwide

Published

on

ronesans-secures-prodigious-ranking-in-enr-list:-9th-european-largest-international-contracting-company,-and-38th-worldwide

ISTANBUL, Sept. 19, 2023 /PRNewswire/ — Rönesans Group has retained its leading construction company status, recently ranked as 38th largest international contracting company worldwide and 9th largest in Europe on ENR’s acclaimed 2023 “World’s Top 250 International Contractors” list. Regarded as the most established international construction industry assessment tool, ENR has ranked Rönesans among the top 10 contracting companies in Europe annually since 2015. This year sees no change, with its reputation secured as the leading Turkish construction company in the world.

 

ENR’s list for 2023 of the “World’s Top 250 International Contractors” is calculated on revenue acquired by contracting companies outside of their headquartered countries. In 2022, along with its JVs, Rönesans achieved a consolidated turnover of $4.3 billion, with more than 70% of its revenue coming from international projects. The company operates in key sectors such as construction, real estate, health, and energy across over 30 countries in Europe, Central Asia, the Middle East, and Africa, and obtained a total turnover of $3.1 billion from abroad, with $2 billion originating from Europe in 2022.

Chair of the board at Rönesans, İpek Ilıcak Kayaalp, states: ‘We are very proud to be listed among the 10 largest European international construction companies for the 8th year running. We will maintain our focus on international growth with the invaluable support of our esteemed international partners in the coming years by participating in more ambitious projects worldwide. We will also keep collaborating with international financial institutions and export financing agencies to jointly deliver numerous impressive projects, including clean water and safe infrastructure solutions to developing parts of the world, as we have recently accomplished in Sri Lanka.”

Ballast Nedam, Rönesans Holding subsidiary company, executed the Clean Water Supply project in Sri Lanka with support and financing provided by the Dutch government and the Dutch export credit agency, Atradius. This significant project aims to provide clean water access to 17,000 households in seven villages within the Hemmathagama region, contributing broadly to Ballast Nedam and Rönesans’ social responsibility and sustainability pillars. Alongside being a driver for Turkish industry growth, Rönesans Holding is keen to implement purposeful campaigns and drive impact in developing communities.

Advertisement
Stake.com

Growing rapidly for the last 30 years, Rönesans Holding, the conglomerate’s top investment entity, has an impressive project portfolio, operating as both main contractor and investor in various sectors, including construction, real estate, healthcare and energy. Key projects include the Lakhta Center, the tallest building in Europe; the Gotthard Base Tunnel, the world’s longest and deepest railway tunnel located in the Swiss Alps; the Gaasperdammertunnel, the longest land tunnel in the Netherlands; the Başakşehir Çam and Sakura Hospital in Turkiye, the world’s largest seismically isolated building; and the Gas to Gasoline Plant (GTG) Project in Turkmenistan, the world’s first and only of its kind.

Under the leadership of its president, Erman Ilıcak, and Chair of the board, İpek Ilıcak Kayaalp, Rönesans has been also substantially increasing its investments in renewable energy for Turkiye after a 50% partnership with Total Energies for Rönesans Enerji last month, with the aim of investing a total of 2 GW of installed capacity in the next 5 years. The agreement is the latest in the company’s long history of successful strategic partnerships from all around the world, having worked with partners and shareholders including the Government of Singapore Investment Corporation (GIC), Meridiam, a Paris-based infrastructure fund, Japanese trading house Sojitz Corporation, and International Finance Corporation (IFC), of the World Bank Group which is a shareholder in Rönesans, and Samsung C&T, among others.

Ranking amongst the top 10 international construction companies in Europe, and top 40 worldwide, Rönesans will continue to drive forward growth across key sectors in Turkiye and globally.

About Rönesans Group 

Rönesans Holding, headquartered in Ankara, is the 38th largest international contracting company globally and the 9th largest in Europe with international operations in 30 countries across Europe, Central Asia, the Middle East and Africa – including Ballast Nedam in the Netherlands and Heitkamp in Germany, Rönesans has been operating as the main contractor and investor successfully for 30 years across construction, real estate development, healthcare and energy. Putting resilience and growth through innovation at the core of the company, with a priority on sustainability and social development, Rönesans has developed projects supporting students with scholarships, academic platforms and initiatives; been a signatory of the UN Global Compact since 2015; and a signatory of the UN Women’s Empowerment Principles since 2016.

Advertisement
Stake.com

Along with its partners GIC, Meridiam Infrastructure, Sojitz, Samsung C&T, TotalEnergies, and IFC, of the World Bank Group (minority shareholder in the group), Rönesans has invested more than EUR7 billion into pioneering projects in Türkiye.

Photo –  https://mma.prnewswire.com/media/2213966/Ipek_Ilicak_Kayaalp.jpg
Photo –  https://mma.prnewswire.com/media/2213965/Ballast_Nedam_Project.jpg
Logo –  https://mma.prnewswire.com/media/2213961/ronesans_holding_Logo.jpg

Water Supply Project by Ballast Nedam, a Rönesans Holding company, to provide clean water access to approximately 17,000 households in seven villages within the Hemmathagama region, Sri Lanka.

 

Ronesans Holding Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/ronesans-secures-prodigious-ranking-in-enr-list-9th-european-largest-international-contracting-company-and-38th-worldwide-301930988.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading

Trending